← 홈

다발성 골수종

229개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 229개
CGTBiologicstaleAllorunning TherapeuticsPhase 1

BCMA/CD19-targeted allogeneic CAR-T (BCMA/CD19-targeted allogeneic CAR-T)

Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma Patients Ineligible or Unwilling to Undergo ASCT; Newly Diagnose… · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 1

BCMA/CD70-targetd CAR-T (BCMA/CD70-targetd CAR-T)

Juvenile Dermatomyositis (JDM); Polyarticular Juvenile Idiopathic Arthritis · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleEssen BiotechPhase 2

BCMA/GPRC5D CAR-T cells (BCMA/GPRC5D CAR-T cells)

Multiple Myeloma; Multiple Myeloma in Relapse · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBiohaven Pharmaceuticals, Inc.Phase 1

BHV-1100 plus cytokine induced memory-like (CIML, BHV-1100 plus cytokine induced memory-like, BHV-1100 plus cytokine induced memory-like (CIML) NK cells plus IVIG and low dose IL-2)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

daratumumab (Darzalex, VTD, Bortezomib, Thalidomide, Dexamethasone, Bortezomib, Thalidomide, Dexamethasone (VTD) + daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleThe General Hospital of Western…Phase 1

CAR 70-BCMA CAR-T (CAR 70-BCMA CAR-T)

Relapsed or Refractory Plasma Cell Neoplasms · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleAffiliated Hospital to Academy …Phase 1

CAR BCMA-CD70-T cells (CAR BCMA-CD70-T cells)

High-risk Plasma Cell Neoplasms · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleSheba Medical CenterPhase 2

CAR-BCMA (CAR-BCMA)

Multiple Myeloma; Relapse Multiple Myeloma · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleKang YUPreclinical

CAR-BCMA T cell (CAR-BCMA T cell)

B Cell Lymphoma; B Cell Leukemia · BCMA

#BCMA#CGT#Preclinical#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleNanjing Legend Biotech Co.Phase 1

CAR-T Re-treatment (CAR-T Re-treatment)

Multiple Myeloma; Multiple Myeloma in Relapse · Multiple Myeloma

#MultipleMyeloma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleShanghai Changzheng HospitalPhase 1

CAR-T cells Infusion (CAR-T cells Infusion)

Relapsed/Refractory Multiple Myeloma; Relapsed/Refractory Plasma Cell Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 67%임상시험 1상태 RECRUITING
CGTBiologicstaleCARsgen Therapeutics Co., Ltd.Phase 1

CAR-T cells Infusion chimeric antigen receptor T cells (CAR-T cells Infusion chimeric antigen receptor T cells)

Relapsed/Refractory Plasma Cell Leukemia; Relapsed/Refractory Multiple Myeloma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleHebei Taihe Chunyu Biotechnolog…Phase 1

CAR19-BCMA dual-target CAR-T (CAR19-BCMA dual-target CAR-T)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleAffiliated Hospital to Academy …Phase 1

CAR19BCMA-T cells (CAR19BCMA-T cells)

Relapsed or Refractory Plasma Cell Neoplasms; Lymphomas/Leukemias With Plasmacytic Differentiation · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
CGTBiologicstaleSorrento Therapeutics, Inc.Phase 1

CAR2 Anti-CD38 A2 CAR-T Cells (CAR2 Anti-CD38 A2 CAR-T Cells)

Relapsed or Refractory Multiple Myeloma · CD38

#CD38#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleChinese PLA General HospitalPhase 2

CART-138 cells (CART-138 cells)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleShanghai Simnova Biotechnology …Phase 1

CART-BCMA (CART-BCMA)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleFundación Pública Andaluza para…Phase 2

CARTemis-1 (CARTemis-1)

Multiple Myeloma; Allogeneic Stem Cell Transplantation · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
ADCBiologicstaleCelgenePhase 1

CC-99712 (CC-99712)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
CGTBiologicstaleNanjing Bioheng Biotech Co., Lt…Phase 1

CD19 or CD19-BCMA CAR-T (CD19 or CD19-BCMA CAR-T)

SLE (Systemic Lupus); Systemic Sclerosis · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING

7 / 12 페이지

← 이전다음 →